These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10230186)

  • 21. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
    Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
    Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice.
    Jensen PS; Bhatara VS; Vitiello B; Hoagwood K; Feil M; Burke LB
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):557-65. PubMed ID: 10230187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of atypical antipsychotics in the treatment of autistic disorder.
    Stachnik JM; Nunn-Thompson C
    Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine treatment of hyperactive and impulsive children with autistic disorder.
    Jaselskis CA; Cook EH; Fletcher KE; Leventhal BL
    J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guanfacine in children with autism and/or intellectual disabilities.
    Handen BL; Sahl R; Hardan AY
    J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Azaspirodecanodiones in clinical psychiatry].
    Conde López V; Martínez Roig M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(4):155-67. PubMed ID: 1356293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naltrexone and communication skills in young children with autism.
    Feldman HM; Kolmen BK; Gonzaga AM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):587-93. PubMed ID: 10230191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic medications in children and adolescents.
    Findling RL; Grcevich SJ; Lopez I; Schulz SC
    J Clin Psychiatry; 1996; 57 Suppl 9():19-23. PubMed ID: 8823346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical review of tricyclic antidepressant use in children and adolescents.
    Geller B; Reising D; Leonard HL; Riddle MA; Walsh BT
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):513-6. PubMed ID: 10230182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperactivity and ADHD.
    Adesman AR
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1262. PubMed ID: 8885579
    [No Abstract]   [Full Text] [Related]  

  • 33. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.
    Hidalgo RB; Tupler LA; Davidson JR
    J Psychopharmacol; 2007 Nov; 21(8):864-72. PubMed ID: 17984162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naltrexone in children with autism.
    Buitelaar JK; Willemsen-Swinkels S; Van Engeland H
    J Am Acad Child Adolesc Psychiatry; 1998 Aug; 37(8):800-2. PubMed ID: 9695440
    [No Abstract]   [Full Text] [Related]  

  • 36. Opiate antagonists in children and adolescents.
    Chabane N; Leboyer M; Mouren-Simeoni MC
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I44-50. PubMed ID: 11140779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
    Desjardins S; Doyen C; Contejean Y; Kaye K; Paubel P
    Encephale; 2009 Apr; 35(2):168-72. PubMed ID: 19393386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Psychopharmacology of autism].
    Chabrol H; Bonnet D; Roge B
    Encephale; 1996; 22(3):197-203. PubMed ID: 8767048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavior-disordered and aggressive children: new advances in pharmacotherapy.
    Campbell M; Anderson LT; Green WH
    J Dev Behav Pediatr; 1983 Dec; 4(4):265-71. PubMed ID: 6582068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.